How we do it: adjunctive intravenous midazolam: diagnosis and treatment of therapy-resistant muscle tension dysphonia.
Dysphonic patients with muscle tension are common at voice clinics. The majority respond to intensive vocal therapy. A small number of cases remain resistant to intensive vocal therapy. We have used intravenous midazolam to enhance therapy-resistant dysphonic patients' self-monitoring, their self-awareness and to change fixed patterns. Six of seven patients were discharged with restoration of normal voice 1 month after treatment.
Bhalla
R K
RK
Department of Otolaryngology, Lancashire Teaching Hospitals NHS Trust, Preston, UK. drrkbhalla@doctors.org.uk
Wallis
J
J
Kaushik
V
V
Carpentier
J P
JP
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007821:Laryngeal Muscles / Q000187:drug effects / Q000503:physiopathology*; D008874:Midazolam / Q000008:administration & dosage / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects; D013070:Speech Therapy / Q000379:methods*; D016896:Treatment Outcome; D014832:Voice Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D014833:Voice Quality
D014151:Anti-Anxiety Agents; D008874:Midazolam